Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International.

Undiagnosed Diseases data sharing developing nations rare diseases survey

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 25 10 2022
accepted: 07 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 22 3 2023
Statut: epublish

Résumé

Rare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden. In October 2020, the Developing Nations Working Group of the Undiagnosed Diseases Network International (DNWG-UDNI) launched a survey among its members, belonging to 20 countries across all continents, to map unmet needs and opportunities for patients with URD. The survey was based on questions with open answers and included eight different domains. Conflicting interpretations were resolved in contact with the partners involved. All members responded to the survey. The results indicated that the scientific and medical centers make substantial efforts to respond to the unmet needs of patients. In most countries, there is a high awareness of RD issues. Scarcity of resources was highlighted as a major problem, leading to reduced availability of diagnostic expertise and research. Serious equity in accessibility to services were highlighted both within and between participating countries. Regulatory problems, including securing informed consent, difficulties in sending DNA to foreign laboratories, protection of intellectual property, and conflicts of interest on the part of service providers, remain issues of concern. Finally, most respondents stressed the need to strengthen international cooperation in terms of data sharing, clinical research, and diagnostic expertise for URD patients in low and medium income countries. The survey highlighted that many countries experienced a discrepancy between the growing expertise and scientific value, the level of awareness and commitment on the part of relevant parties, and funding bodies. Country-tailored public health actions, including general syllabus of medical schools and of the education of other health professionals, are needed to reduce such gaps.

Identifiants

pubmed: 36935719
doi: 10.3389/fpubh.2023.1079601
pmc: PMC10017550
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1079601

Informations de copyright

Copyright © 2023 Taruscio, Salvatore, Lumaka, Carta, Cellai, Ferrari, Sciascia, Groft, Alanay, Azam, Baynam, Cederroth, Cutiongco-de la Paz, Dissanayake, Giugliani, Gonzaga-Jauregui, Hettiarachchi, Kvlividze, Landoure, Makay, Melegh, Ozbek, Puri, Romero, Scaria, Jamuar, Shotelersuk, Roccatello, Gahl, Wiafe, Bodamer and Posada.

Déclaration de conflit d'intérêts

SW was employed by Rare Disease Ghana Initiative. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Biotechnol. 2021 Jun;39(6):671-677
pubmed: 34089038
Orphanet J Rare Dis. 2018 Feb 1;13(1):15
pubmed: 29386040
Acta Paediatr. 2021 Oct;110(10):2711-2716
pubmed: 34105798
Clin Genet. 2021 Jul;100(1):100-105
pubmed: 33822359
Eur J Hum Genet. 2020 Feb;28(2):165-173
pubmed: 31527858
Eur J Hum Genet. 2019 Oct;27(10):1485-1492
pubmed: 31101884
Am J Med Genet C Semin Med Genet. 2019 Jun;181(2):245-253
pubmed: 30888117
Clin Genet. 2021 Dec;100(6):703-712
pubmed: 34496037
Orphanet J Rare Dis. 2022 Jun 18;17(1):233
pubmed: 35717227
Br J Gen Pract. 2017 May;67(658):231-232
pubmed: 28450341
Genet Test Mol Biomarkers. 2021 Dec;25(12):733-734
pubmed: 34918980
Front Pediatr. 2020 Dec 14;8:579924
pubmed: 33381478
Lancet. 2008 Sep 13;372(9642):889-90
pubmed: 18790305
Genet Test Mol Biomarkers. 2022 Mar;26(3):105-106
pubmed: 35349374
Int J Environ Res Public Health. 2022 May 26;19(11):
pubmed: 35682039
Mol Genet Metab. 2020 Apr;129(4):243-254
pubmed: 32033911
Orphanet J Rare Dis. 2013 Feb 11;8:22
pubmed: 23398775
Mol Genet Metab. 2015 Dec;116(4):223-5
pubmed: 26596705
Eur Respir Rev. 2020 Jul 3;29(156):
pubmed: 32620589

Auteurs

Domenica Taruscio (D)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Marco Salvatore (M)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Aimè Lumaka (A)

Reference Center for Rare and Undiagnosed Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Service de Génétique Humaine, University Hospitals of Liège, Liège, Belgium.

Claudio Carta (C)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Laura L Cellai (LL)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Gianluca Ferrari (G)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Savino Sciascia (S)

Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) With Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.

Stephen Groft (S)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.

Yasemin Alanay (Y)

ACURARE-Rare and Undiagnosed Diseases Center, Acibadem University, Istanbul, Turkey.

Maleeha Azam (M)

COMSATS University Islamabad, Islamabad, Pakistan.

Gareth Baynam (G)

Rare Care, Clinical Centre of Expertise for Rare and Undiagnosed Diseases, Perth Children's Hospital, Perth, WA, Australia.

Helene Cederroth (H)

Wilhelm Foundation, Stockholm, Sweden.

Eva Maria Cutiongco-de la Paz (EM)

Institute of Human Genetics, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.

Vajira Harshadeva Weerabaddana Dissanayake (VHW)

Department of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Roberto Giugliani (R)

House of Rares, Medical Genetics Service, HCPA, Department Genetics UFRGS and DASA, Porto Alegre, Brazil.

Claudia Gonzaga-Jauregui (C)

International Laboratory for Human Genome Research, Universidad Nacional Autonoma de Mexico, Juriquilla, Queretaro, Mexico.

Dineshani Hettiarachchi (D)

Department of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Oleg Kvlividze (O)

Georgian Foundation for Genetic and Rare Diseases (GeRaD), School of Medicine, New Vision University, Tbilisi, Georgia.

Guida Landoure (G)

Faculté de Médecine et d'Odontostomatologie, l'Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali.

Prince Makay (P)

Reference Center for Rare and Undiagnosed Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo.

Béla Melegh (B)

Department of Medical Genetics, School of Medicine, University of Pécs, Pécs, Hungary.

Ugur Ozbek (U)

ACURARE-Rare and Undiagnosed Diseases Center, Acibadem University, Istanbul, Turkey.

Ratna Dua Puri (RD)

Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.

Vanessa Romero (V)

School of Medicine, Universidad San Francisco de Quito, Quito, Ecuador.

Vinod Scaria (V)

CSIR Institute of Genomics and Integrative Biology, New Delhi, India.

Saumya S Jamuar (SS)

Singhealth Duke-NUS Genomic Medicine Centre, KK Women's and Children's Hospital, Singapore, Singapore.
SingHealth Duke-NUS Institute of Precision Medicine, Singapore, Singapore.

Vorasuk Shotelersuk (V)

Center of Excellence for Medical Genomics, Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand.

Dario Roccatello (D)

Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) With Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.

William A Gahl (WA)

National Institutes of Health, National Human Genome Research Institute, Bethesda, MD, United States.

Samuel A Wiafe (SA)

Rare Disease Ghana Initiative, Accra, Ghana.

Olaf Bodamer (O)

Division of Genetics and Genomics, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.

Manuel Posada (M)

Rare Diseases Research Institute (IIER), SpainUDP, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH